Skip to content
Search

Latest Stories

Henry Gregg named as new NPA chief executive

Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.


“I am excited to be joining the NPA at a pivotal time for community pharmacy. I’m looking forward to working with the NPA team, building strong links with government so we can deliver the support pharmacies so desperately need and the bigger role they can undoubtedly play in everyone’s health,” said Gregg.

“I want to focus on fighting for pharmacies and raising the profile of their amazing work, but also making sure the NPA is offering the best possible service and support for a network upon which so many people rely. I can’t wait to meet the team and start meeting NPA members across the UK.”

At Asthma + Lung UK, Gregg has led the campaign to ban cigarettes for everyone born after 2009 and smoking outside hospitals, playgrounds and schools, and also pushed for respiratory vaccines and management of lung conditions in community pharmacies.

Having started his career working in parliament, Gregg went on to gain a wealth of communications, policy and public experience at the Health Foundation and the London Boroughs of Newham and Barking and Dagenham.

He also led member relations at the National Housing Federation, where he supported the housing sector in the aftermath of the Grenfell Tower fire.

Nick Kaye, NPA chair, said: “On behalf of the NPA board I am so delighted to be welcoming Henry to join the NPA as its next chief executive.

“At a time of huge change and enormous opportunity for the community pharmacy network, we are fortunate to have someone with Henry’s experience and insight to lead the organisation as we respond to the challenges ahead.

“The NPA has made tremendous strides over the past months and has given community pharmacy a greater profile than ever before. I’m sure Henry will build on that work to modernise the NPA and ensure we are the strongest possible advocate and servant for the thousands of NPA member pharmacies that are a central part of the health service for millions of people.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less